Dr. Enelow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-5533Fax+1 203-785-6414
Education & Training
- University of Virginia Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1984 - 1986
- Emory University School of MedicineInternship, Internal Medicine, 1983 - 1984
- Boston University School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1986 - Present
- VT State Medical License 2021 - 2026
- NH State Medical License 2007 - 2025
- ME State Medical License 2020 - 2021
- CT State Medical License 2003 - 2008
- VA State Medical License 1988 - 2004
- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2007, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Top Doctors: New York Metro Area Castle Connolly, 2006-2008
- Join now to see all
Clinical Trials
- STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2012 Jul 16
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsSingle-cell RNA-seq Analysis Reveals That Prenatal Arsenic Exposure Results in Long-term, Adverse Effects on Immune Gene Expression in Response to Influenza A InfectionKevin S Hsu, Britton C. Goodale, Kenneth H. Ely, Thomas H. Hampton, Bruce A Stanton
Toxicological Sciences. 2020-08-01 - 38 citationsSTAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection.Radha Gopal, Benjamin Lee, Kevin J. McHugh, Helen E. Rich, Krishnaveni Ramanan
Frontiers in Immunology. 2018-09-25 - 29 citationsVolatile fingerprinting of human respiratory viruses from cell culture.Giorgia Purcaro, Christiaan A. Rees, Wendy Wieland-Alter, Mark J. Schneider, Xi Wang
Journal of Breath Research. 2018-03-01
Grant Support
- Innate Regulation Of CD8+ T Cell Effector ActivitesNational Institute Of Allergy And Infectious Diseases2009–2011
- TNF Processing In Pulmonary ImmunopathologyNational Institute Of Allergy And Infectious Diseases2007–2011
- Type I Interferon Regulation Of Immunopathology In Influenza PneumoniaNational Center For Research Resources2010
- Type I Interferon Reulation Of Immunopathology In Influenza PneumoniaNational Center For Research Resources2008–2009
- Interferon-Gamma In Experimental Pulmonary FibrosisNational Heart, Lung, And Blood Institute2003–2005
- Mechanisms Of Cell-Mediated Lung InjuryNational Heart, Lung, And Blood Institute2003
- Interferon-Gamma In Experimental Pulmonary FibrosisNational Heart, Lung, And Blood Institute2002
- Mechanisms Of Cell-Mediated Lung InjuryNational Heart, Lung, And Blood Institute2000–2002
- Mechanisms Of T Cell Mediated Lung InjuryNational Heart, Lung, And Blood Institute1997–1999
- Antigen Processing In The LungNational Heart, Lung, And Blood Institute1992–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: